Science Explorer Back to mapMap
Discussion
Researcher · Medical University of Lodz · Poland

Tadeusz Robak

Tadeusz Robak publishes mostly in Genetics, Hematology and Pathology and Forensic Medicine, on topics such as Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment and Acute Lymphoblastic Leukemia research.

ORCID 0000-0002-3411-6357 OpenAlex
World rank
#1,492,558
of 7,710,434 ranked researchers
Rank in Poland
#8,931
of 100,960
Works
1,219
Citations
38k
Citations per work
31.3
h-index
81
i10-index 484Top 1% in Genetics (Medicine)
Tadeusz Robak

What does Tadeusz Robak research?

Tadeusz Robak's work is mostly in Medicine (57%), Biochemistry, Genetics and Molecular Biology (9%), Immunology and Microbiology (9%).

Health Sciences: 694 works · 56.9% of their workMedicine: 694 works · 56.9% of their workGenetics: 263 works · 21.6% of their workHematology: 172 works · 14.1% of their workPathology and Forensic Medicine: 154 works · 12.6% of their workOncology: 105 works · 8.6% of their workEverything else: 301 works · 24.7% of their workLife Sciences: 224 works · 18.4% of their workBiochemistry, Genetics and Molecular Biology: 112 works · 9.2% of their workMolecular Biology: 112 works · 9.2% of their workImmunology and Microbiology: 112 works · 9.2% of their workImmunology: 112 works · 9.2% of their workTHEIR WORKTadeusz Robak1,219works
Life Sciences18%Health Sciences57%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine69456.9%
  2. Everything else30124.7%
    1. Biochemistry, Genetics and Molecular Biology1129.2%
    2. Immunology and Microbiology1129.2%
  1. 1Genetics22% of their works
  2. 2Hematology14% of their works
  3. 3Pathology and Forensic Medicine13% of their works
  4. 4Immunology9% of their works
  5. 5Molecular Biology9% of their works
  6. 6Oncology9% of their works

Research topics

Which keywords describe Tadeusz Robak's research?

The keywords of their largest research topics: Rituximab, Prognostic Factors, Chronic Lymphocytic Leukemia, Genomic Aberrations, Classification, Lymphoma, Minimal Residual Disease and Acute Lymphoblastic Leukemia.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Rituximab1,0272 topics
  2. Prognostic Factors9353 topics
  3. Chronic Lymphocytic Leukemia6551 topic
  4. Genomic Aberrations6551 topic
  5. Classification3721 topic
  6. Lymphoma3721 topic
  7. Minimal Residual Disease2642 topics
  8. Acute Lymphoblastic Leukemia1611 topic
  9. Childhood Cancer1611 topic
  10. Genetic Mutations1531 topic
  11. Primary Immunodeficiency1531 topic
  12. BCR-ABL1371 topic
  13. Imatinib1371 topic
  14. AML1191 topic
  15. Acute Myeloid Leukemia1191 topic
  16. Diagnosis Criteria1031 topic
  17. International Myeloma Working Group1031 topic
  18. Fc Receptors821 topic
  19. Therapeutic Antibodies821 topic

Where does Tadeusz Robak work?

Tadeusz Robak's main affiliation in the publication record is Medical University of Lodz, Poland.

How many publications and citations does Tadeusz Robak have?

OpenAlex counts 1,219 works and 38,112 citations for Tadeusz Robak, an h-index of 81, ranking #1,492,558 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Tadeusz Robak. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.